Zacks Investment Research | Dec 03, 2018 08:48PM ET
Procter & Gamble Company (NYSE:PG) , commonly known as P&G, completed its previously announced acquisition of the consumer-health business of Germany-based Merck KGaA. Agreed upon in April 2018, the acquisition includes Merck KGaA’s consumer health business worth $1 billion that provides a wide range of over-the-counter (OTC) products for relieving pain as well as for supporting physical activity and mobility. Additionally, it will acquire a 51.8% stake in India-listed Merck Ltd.
This buyout is likely to bolster P&G’s OTC geographic footprint as Merck KGaA’s consumer health business is active in 44 countries and includes more than 900 products. The addition of Merck KGaA’s differentiated and physician-supported brands will enhance P&G's existing consumer healthcare capabilities and brands such as Vicks, Pepto-Bismol, and Oral-B. It is expected to boost the company’s brand portfolio and category footprint in most of the world’s top 15 OTC markets.
P&G believes that the acquisition will also provide strong healthcare commercial and supply capabilities, deep technical mastery, and proven consumer healthcare leadership. As part of this acquisition, P&G created a new healthcare organization, which will enable consumers to live longer, healthier and more vibrant lives as well as boost the company’s sales and profits.
With this acquisition, the president and CEO of Merck KGaA Consumer Health, Uta Kemmerich-Keil, will lead P&G’s Personal Healthcare International. This organization encompasses the recently merged consumer healthcare businesses in Europe, Latin America and Asia/IMEA (India, the Middle East and Africa).
Additionally, the company expects the transaction to boost its focus on science and technology. These new brands will expand the company’s OTC product offerings, capable of relieving muscle, joint and back pain, cold, and headache. Moreover, these offerings will include products for enhancing physical activity and mobility.
Conclusively, we believe the acquisition not only complements P&G’s existing consumer healthcare capabilities and brands but is also capable of expanding the company’s position in the largest and fast-growing segments in the consumer health market.
P&G's shares did not react much to the news. However, this Zacks Rank #3 (Hold) stock gained 12.1% in the last three months, outperforming the industry ’s 6% growth.
Looking for Better-Ranked Consumer Staples Stocks? Check These
Church & Dwight Co., Inc. (NYSE:CHD) has a Zacks Rank #2 (Buy) and average long-term EPS growth rate of 10.1%. You can see Original post
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.